Samra Turajlic M.D. Consultant Medical Oncologist at The Royal Marsden specialising in the treatment of kidney cancer and melanoma Discusses…
Browsing: Kidney
Samra Turajlic M.D. Consultant Medical Oncologist at The Royal Marsden specialising in the treatment of kidney cancer and melanoma Discusses…
Samra Turajlic M.D. Consultant Medical Oncologist at The Royal Marsden specialising in the treatment of kidney cancer and melanoma Discusses…
Samra Turajlic M.D. Consultant Medical Oncologist at The Royal Marsden specialising in the treatment of kidney cancer and melanoma Discusses…
Samra Turajlic M.D. Consultant Medical Oncologist at The Royal Marsden specialising in the treatment of kidney cancer and melanoma Discusses…
Samra Turajlic M.D. Consultant Medical Oncologist at The Royal Marsden specialising in the treatment of kidney cancer and melanoma Discusses…
Daniel Goldstein MD Tel Aviv University discusses Moving from Observational Pharmacoeconomics to Interventional Pharmacoeconomics at the Kidney Cancer Association International…
Cristina Suárez MD PhD Hospital Universitari Vall d´Hebron-Vall d´Hebron Institute of Oncology discusses SPAIN: SOGUG MODEL at the Kidney Cancer…
Tim OBrien Vice President of BAUS discusses Centralization of Nephrectomy in the UK The good the bad and the ugly…
Toni K. Choueiri, MD Director, The Lank Center for Genitourinary Oncology Dana-Farber Cancer Institute discusses The Combination of Avelumab +…
Ronan FlippotMD MSc discusses Brain Metastases in Renal Cell CarcinomaAre immune checkpoint inhibitors up to the task? discusses Brain Metastases…
Raquel Perez-Lopez Vall dHebron Institute of Oncology (VHIO)Principal Investigator-Radiomics Group discusses Recist vs iRecist: Clinically Significant? at the Kidney Cancer…
Frede Donskov, M.D., DMSc Professor of Oncology Chairman, Kidney Cancer Expert Committee, Danish Medicines Council Aarhus University Hospital Denmark discusses…
Brian i. Rini, MD Cleveland Clinic discusses Axi/Pembro is the Standard of Care in mRCC at the Kidney Cancer Association…
Samra Turajlic The Royal Marsden NHS Foundation Trust, London, UK discusses the second part of A phase II study of…
Dr Pablo Maroto Hospital Sant Pau Barcelona discusses New Network Around Oncologists at the Kidney Cancer Association International Symposium 2019…
Jean-Marie Michot, MD Drug Development Department Gustave Roussy, France jean-marie.michot@gustaveroussy.fr discusses IO toxicities in Kidney Cancer at the Kidney Cancer…
Jose A. Karam, MD, FACS Associate Professor Departments of Urology and Translational Molecular Pathology discusses  Update in IO Neoadjuvant (Preoperative)…
Cristina Suárez MD PhD Hospital Universitari Vall d´Hebron-Vall d´Hebron Institute of Oncology discusses NEW TARGETS IN RCC:NKTR at the Kidney…
Brian Shuch, MD Associate Professor of Urology Director, UCLA Kidney Cancer Program Alvin & Carrie Meinhardt Endowed Chair in Kidney Cancer…
Monika Wolkers, PhD m.wolkers@sanquin.nl discusses TIL products from Renal Cell Carcinomas are tumor-specific but poor cytokine producers at the Kidney…
Bernadett Szabados of Barts Cancer Institute discusses NEW TARGETS IN RCC at the Kidney Cancer Association International Symposium 2019 in…
W. Kimryn Rathmell, MD, PhD of Vanderbilt Ingram Cancer Center discusses Novel epigenetic targeting approaches at the Kidney Cancer Association…
Toni K. Choueiri MD of Dana Farber discusses Randomised phase 2 study of sapanisertib (TAK?228/MLN0128) ± TAK-117 versus everolimus in…
Philip Zeuschner, MD of Universität des Saarlandes, Saarbrücken (UKS) discusses Learning curves in 500 robot-assisted partial nephrectomies: the bed-side assistant…
Prof. Alessandro VOLPE University of Eastern Piedmont Maggiore della Carità Hospital, Novara, Italy discusses SMALL RENAL MASSES NON SURGICAL MANAGEMENT…
Manuela Schmidinger, MD, Camillo Porta, MD, Romano Danesi, MD, PhD, Brian I. Rini, MD discuss Optimising advanced RCC treatment: the…
Dr Emmanuel MEYER Department of radiation oncology Centre François Baclesse Caen – France discusses Oligometastatic disease: Localized vs systemic therapy…
Fernando Gómez Muñoz. MD PhD Vascular and Interventional Radiology Hospital Clinic de Barcelona Hospital Sant Joan de Deu, Barcelona Netherlands…
Stereotactic Ablative Body RadioTherapy in Kidney Cancer Ben Vanneste, MD, PhD Radiation-Oncologist, MAASTRO Clinic, The Netherlands discusses Stereotactic Ablative Body…
Dr Kevin Litchfield Kevin.litchfield@crick.ac.uk Twitter: @kevlitchfield discusses Genomic and Transcriptomic Biomarkers of IO Response in RCC at the Kidney Cancer…
Grant D Stewart, MD Surgical Oncology Lead, University Lecturer, University of Cambridge Consultant Urological Surgeon, Addenbrookes Hospital discusses Adjuvant immuno-oncology…
James Larkin of the The Royal Marsden NHS Foundation Trust pays tribute to his friend and legendary oncologist Martin Gore…
Thomas Powles Director of Barts Cancer Center. Professor of Urology Cancer, Barts Cancer Institute discusses firist line clear cell RCC:…
W. Kimryn Rathmell, MD, PhD Director of the Division of Hematology and Oncology Vanderbilt University Medical Center discusses Endogenous retrovirus…
Samra Turajlic, MD The Royal Marsden NHS Foundation Trust outlines Cell-free tumour DNA (cfDNA) detection in advanced renal cell carcinoma…
Christopher Wood, MD MD Anderson Cancer Center expresses his thoughts on the late Martin Gore at the Kidney Cancer Association…
David Quinn, MD USC Norris Comprehensive Cancer Center gives a heartfelt tribute to Dr. Martin Gore and his US/International Perspective…
Bernard Escudier of the Institut Gustave Roussy in Villejuif, France reminisces about his late friend Martin Gore at the Kidney…
Tobias Klatte, MD, PhD, FEBU, FRCS(Ed) Consultant Urological Surgeon, Royal Bournemouth Hospital Visiting Researcher, University of Cambridge Honorary Lecturer, University…
This presentation aims to provide an overview of the mRCC patient journey and the challenges clinicians face. To explore how…
Andy Thomas from Kidney Cancer Support Network discusses Cytoreductive Nephrectomy Patient Perspective at the Kidney Cancer Association International Symposium in…
Axel Bex Royal Free London NHS Foundation Trust, UCL Division of Surgical and Interventional Science, London, UK and The Netherlands…
Michael Staehler, M.D. Ph.D. Head Interdisciplinary Center on Renal Tumors Department of Urology University of Munich, Germany takes the PROCytoreductive…
Lorenzo Marconi, MD, FEBU Coimbra, Portugal discusses Clinical Marker for Cytoreductive Nephrectomy? at the Kidney Cancer International Symposium in Dubrovnik…
Tian Zhang, MD, Assistant Professor of Medicine, Duke Cancer Institute, Discusses Discussing PEDIGREE Study. At The 2019 Genitourinary Cancers Symposium…
Rana McKay, MD, Medical Oncologist, Assistant Professor of Medicine, University of California, San Diego, Discusses Recent Data Examining Atezolizumab And…
Rana McKay, MD, Medical Oncologist, Assistant Professor of Medicine, University of California, San Diego, Discusses The Implications Of CHECKMATE 214…
Rana McKay, MD, Medical Oncologist, Assistant Professor of Medicine, University of California, San Diego, Discusses Outcomes Of The KEYNOTE 426…
Rana McKay, MD, Medical Oncologist, Assistant Professor of Medicine, University of California, San Diego, Discusses TIVO-3 Study In Highly Refractory…